CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

DNLIDenali Therapeutics Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $20.67 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$3.30B
RECENT INSIDER TRADES
  • 2026-09-09 · Chin Peter Scott (Chief Medical Officer) · SELL
  • 2026-09-04 · Thornberry Nancy (Director) · SELL
  • 2026-09-03 · Schuth Alexander O. (COFO and Secretary) · SELL
  • 2026-08-14 · Watts Ryan J. (President and CEO) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders318
Shares held184,476,527
Value$4.05B
Percent of shares outstanding115.41%
As of quarter end2026-06-30
RECENT NEWS
  • Denali Therapeutics presents at Morgan Stanley healthcare conference
  • Denali Therapeutics presents at Morgan Stanley conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Denali Therapeutics Inc. (DNLI) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit